These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 32438474)

  • 21. Engineering of Solid Dosage Forms of siRNA-Loaded Lipidoid-Polymer Hybrid Nanoparticles Using a Quality-by-Design Approach.
    Lokras A; Foged C; Thakur A
    Methods Mol Biol; 2021; 2282():137-157. PubMed ID: 33928574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combinatorially designed lipid-like nanoparticles for intracellular delivery of cytotoxic protein for cancer therapy.
    Wang M; Alberti K; Sun S; Arellano CL; Xu Q
    Angew Chem Int Ed Engl; 2014 Mar; 53(11):2893-8. PubMed ID: 24519972
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Myocardial Delivery of Lipidoid Nanoparticle Carrying modRNA Induces Rapid and Transient Expression.
    Turnbull IC; Eltoukhy AA; Fish KM; Nonnenmacher M; Ishikawa K; Chen J; Hajjar RJ; Anderson DG; Costa KD
    Mol Ther; 2016 Feb; 24(1):66-75. PubMed ID: 26471463
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The replacement of helper lipids with charged alternatives in lipid nanoparticles facilitates targeted mRNA delivery to the spleen and lungs.
    LoPresti ST; Arral ML; Chaudhary N; Whitehead KA
    J Control Release; 2022 May; 345():819-831. PubMed ID: 35346768
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modular Design of Biodegradable Ionizable Lipids for Improved mRNA Delivery and Precise Cancer Metastasis Delineation In Vivo.
    Chen Z; Tian Y; Yang J; Wu F; Liu S; Cao W; Xu W; Hu T; Siegwart DJ; Xiong H
    J Am Chem Soc; 2023 Nov; 145(44):24302-24314. PubMed ID: 37853662
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant lipidoid-substituted lipid nanoparticles augment the immunogenicity of SARS-CoV-2 mRNA vaccines.
    Han X; Alameh MG; Butowska K; Knox JJ; Lundgreen K; Ghattas M; Gong N; Xue L; Xu Y; Lavertu M; Bates P; Xu J; Nie G; Zhong Y; Weissman D; Mitchell MJ
    Nat Nanotechnol; 2023 Sep; 18(9):1105-1114. PubMed ID: 37365276
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Systemic mRNA Delivery to the Lungs by Functional Polyester-based Carriers.
    Yan Y; Xiong H; Zhang X; Cheng Q; Siegwart DJ
    Biomacromolecules; 2017 Dec; 18(12):4307-4315. PubMed ID: 29141136
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mechanistic profiling of the release kinetics of siRNA from lipidoid-polymer hybrid nanoparticles in vitro and in vivo after pulmonary administration.
    Thanki K; van Eetvelde D; Geyer A; Fraire J; Hendrix R; Van Eygen H; Putteman E; Sami H; de Souza Carvalho-Wodarz C; Franzyk H; Nielsen HM; Braeckmans K; Lehr CM; Ogris M; Foged C
    J Control Release; 2019 Sep; 310():82-93. PubMed ID: 31398360
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel local anti-colorectal cancer drug delivery system: negative lipidoid nanoparticles with a passive target via a size-dependent pattern.
    Ding W; Wang F; Zhang J; Guo Y; Ju S; Wang H
    Nanotechnology; 2013 Sep; 24(37):375101. PubMed ID: 23965897
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lipid Nanoparticle-mRNA Formulations for Therapeutic Applications.
    Wang C; Zhang Y; Dong Y
    Acc Chem Res; 2021 Dec; 54(23):4283-4293. PubMed ID: 34793124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peptide-encoding mRNA barcodes for the high-throughput in vivo screening of libraries of lipid nanoparticles for mRNA delivery.
    Rhym LH; Manan RS; Koller A; Stephanie G; Anderson DG
    Nat Biomed Eng; 2023 Jul; 7(7):901-910. PubMed ID: 37127709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid-mRNA Nanoparticle Designed to Enhance Intracellular Delivery Mediated by Shock Waves.
    Zhang J; Shrivastava S; Cleveland RO; Rabbitts TH
    ACS Appl Mater Interfaces; 2019 Mar; 11(11):10481-10491. PubMed ID: 30788952
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemical Modification of Proteins and Their Intracellular Delivery Using Lipidoid Nanoparticles.
    Li Y; Glass Z; Xu Q
    Methods Mol Biol; 2022; 2394():555-573. PubMed ID: 35094346
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Lipidoid Nanoparticles for siRNA Delivery to Neural Cells.
    Khare P; Dave KM; Kamte YS; Manoharan MA; O'Donnell LA; Manickam DS
    AAPS J; 2021 Dec; 24(1):8. PubMed ID: 34873640
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity Testing of Lipidoids In Vitro and In Silico: Modulating Lipidoid-Mediated TLR4 Activation by Nanoparticle Design.
    de Groot AM; Thanki K; Gangloff M; Falkenberg E; Zeng X; van Bijnen DCJ; van Eden W; Franzyk H; Nielsen HM; Broere F; Gay NJ; Foged C; Sijts AJAM
    Mol Ther Nucleic Acids; 2018 Jun; 11():159-169. PubMed ID: 29858051
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo mRNA delivery using lipid-enveloped pH-responsive polymer nanoparticles.
    Su X; Fricke J; Kavanagh DG; Irvine DJ
    Mol Pharm; 2011 Jun; 8(3):774-87. PubMed ID: 21417235
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ionizable lipid nanoparticles encapsulating barcoded mRNA for accelerated in vivo delivery screening.
    Guimaraes PPG; Zhang R; Spektor R; Tan M; Chung A; Billingsley MM; El-Mayta R; Riley RS; Wang L; Wilson JM; Mitchell MJ
    J Control Release; 2019 Dec; 316():404-417. PubMed ID: 31678653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Combinatorial Synthesis of a Lipidoid Library by Thiolactone Chemistry:
    Molla MR; Chakraborty S; Munoz Sagredo L; Drechsler M; Orian Rousseau V; Levkin PA
    Bioconjug Chem; 2020 Mar; 31(3):852-860. PubMed ID: 32068393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes.
    Pardi N; Tuyishime S; Muramatsu H; Kariko K; Mui BL; Tam YK; Madden TD; Hope MJ; Weissman D
    J Control Release; 2015 Nov; 217():345-51. PubMed ID: 26264835
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Lung-selective mRNA delivery of synthetic lipid nanoparticles for the treatment of pulmonary lymphangioleiomyomatosis.
    Qiu M; Tang Y; Chen J; Muriph R; Ye Z; Huang C; Evans J; Henske EP; Xu Q
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35173043
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.